![](/img/cover-not-exists.png)
A PHASE II, OPEN-LABEL, PROSPECTIVE STUDY (TAPER) TO ASSESS THE ABILITY OF ELTROMBOPAG TO INDUCE SUSTAINED TREATMENT-FREE REMISSION IN ITP PATIENTS WITH INSUFFICIENT RESPONSE TO CORTICOSTEROIDS
Cooper, N., Ghanima, W., Haenig, J., Jha, J., Lee, J., Zaja, F.Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000567480.47134.f7
Date:
June, 2019
File:
PDF, 561 KB
2019